Meetings

  • First Meeting of the Committee on Functional Assessment for Adults with Disabilities Date: December 7, 2017 (10:00 AM Eastern)

    The first meeting of the Committee on Functional Assessment for Adults with Disabilities was held in Washington, DC on December 7, 2017.
  • Making Medicines Affordable: A National Imperative Report Release Event Date: November 30, 2017 (1:00 PM Eastern)

    The National Academies of Sciences, Engineering, and Medicine will release and discuss the findings of their new affordable drugs report at a National Press Club Headliners Newsmaker this Thursday, November 30, 2017 at 1:00PM in the club’s Fourth Estate.
  • Meeting II and Public Workshop for the Committee On Ensuring Patient Access To Affordable Drug Therapies Date: December 13, 2016 (9:00 AM Eastern)

    The Committee on Ensuring Patient Access to Affordable Drug Therapies' second meeting will be a public workshop.
  • Meeting I for the Committee On Ensuring Patient Access To Affordable Drug Therapies Date: November 14, 2016 - November 15, 2016 (8:00 AM Eastern)

    Committee on Ensuring Patient Access to Affordable Drug Therapies will be holding their first meeting in the NAS Building. There will be opportunity for public comment.
  • Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology Date: July 20, 2015 - July 21, 2015 (8:00 AM Eastern)

    This IOM workshop will examine the clinical benefits and comparative effectiveness of emerging advanced technologies for cancer treatment in radiation therapy and surgery. Workshop participants will discuss current utilization patterns, with a focus on diffusion of new technologies into oncology practice, as well as evidence on the overuse, underuse, and misuse of these technologies, and potential strategies to assess the value and define optimal use of new technologies in cancer treatment.
  • Care Culture and Decision-making Innovation Collaborative Date: June 5, 2015 (9:00 AM Eastern)

    At this meeting, participants will review tools, strategies, and priorities in the roles of clinicians, patients, and families in shared decision making for advanced illness and end-of-life circumstances; review progress and next steps related to stakeholder roles in transforming shared decision making into a routine element of patient care; and identify possible collaborative activities for ECIC participants to facilitate progress.
  • Meeting 2: Committee for Assessing Progress in Implementing the Recommendations of the IOM Report The Future of Nursing: Leading Change, Advancing Health Date: May 28, 2015 (9:00 AM Eastern)

    The second meeting of the IOM Committee for Assessing Progress on Implementing the Recommendations of the IOM Report The Future of Nursing: Leading Change, Advancing Health was held on May 28-29, 2015.
  • Report Release: Vital Signs Date: April 28, 2015 (2:30 PM Eastern)

    The IOM and the Committee on Core Metrics for Better Health at Lower Cost will release their report to the public on April 28, 2015 in Washington, DC.
  • Report Release Announcement Date: April 14, 2015 (11:00 AM Eastern)

    The IOM and the Committee on the Public Health Dimensions of Cognitive Aging released their report to the public on April 14, 2015 in Washington, DC.
  • Comprehensive Cancer Care for Children and their Families Date: March 9, 2015 - March 10, 2015 (8:00 AM Eastern)

    Through invited presentations and panel discussions, this workshop hosted by the NCPF and the American Cancer Society (ACS) will examine recent trends in comprehensive cancer care for pediatric cancer patients and their families and consider potential policy actions to improve care and outcomes. Participants will review existing evidence and efforts for integrating pediatric palliative care and quality of life strategies in childhood oncology research and practice, and will discuss additional research needed to minimize toxicities of pediatric cancer treatments and the resultant symptoms and late effects. A major goal of the workshop will be to facilitate discussion about potential strategies and actions for effectively applying existing evidence and quality of life strategies into pediatric oncology research, development, and practice.